{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:54:20Z","timestamp":1781571260615,"version":"3.54.5"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Innovative Medicines Initiative 2 Joint Undertaking","award":["806776"],"award-info":[{"award-number":["806776"]}]},{"name":"Innovative Medicines Initiative 2 Joint Undertaking","award":["806776"],"award-info":[{"award-number":["806776"]}]},{"name":"Innovative Medicines Initiative 2 Joint Undertaking","award":["806776"],"award-info":[{"award-number":["806776"]}]},{"name":"Innovative Medicines Initiative 2 Joint Undertaking","award":["806776"],"award-info":[{"award-number":["806776"]}]},{"name":"Innovative Medicines Initiative 2 Joint Undertaking","award":["806776"],"award-info":[{"award-number":["806776"]}]},{"name":"Innovative Medicines Initiative 2 Joint Undertaking","award":["806776"],"award-info":[{"award-number":["806776"]}]},{"name":"Innovative Medicines Initiative 2 Joint Undertaking","award":["806776"],"award-info":[{"award-number":["806776"]}]},{"name":"Innovative Medicines Initiative 2 Joint Undertaking","award":["806776"],"award-info":[{"award-number":["806776"]}]},{"name":"Innovative Medicines Initiative 2 Joint Undertaking","award":["806776"],"award-info":[{"award-number":["806776"]}]},{"name":"University of Bordeaux doctorate school program"},{"DOI":"10.13039\/501100002999","name":"Dutch Ministry of Health, Welfare and Sport","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002999","id-type":"DOI","asserted-by":"crossref"}]},{"name":"University of Bordeaux Senior IdEx Chair"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"DOI":"10.1038\/s41541-026-01437-5","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T15:19:57Z","timestamp":1775834397000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Influenza vaccine-specific CD4+ T cell responses are impaired in older adults"],"prefix":"10.1038","volume":"11","author":[{"given":"Pauline","family":"Saint-Charles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Hagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00eblle","family":"Autaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elske","family":"Bijvank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Beckers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josine","family":"van Beek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie","family":"van Baarle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Weinberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Appay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"key":"1437_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrmicro.2017.118","volume":"16","author":"VN Petrova","year":"2018","unstructured":"Petrova, V. N. & Russell, C. A. The evolution of seasonal influenza viruses. Nat. Rev. Microbiol. 16, 47\u201360 (2018).","journal-title":"Nat. Rev. Microbiol."},{"key":"1437_CR2","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1093\/cid\/ciz075","volume":"69","author":"MA Rolfes","year":"2019","unstructured":"Rolfes, M. A. et al. Effects of influenza vaccination in the United States during the 2017-2018 influenza season. Clin. Infect. Dis. 69, 1845\u20131853 (2019).","journal-title":"Clin. Infect. Dis."},{"key":"1437_CR3","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","volume":"391","author":"AD Iuliano","year":"2018","unstructured":"Iuliano, A. D. et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet 391, 1285\u20131300 (2018).","journal-title":"Lancet"},{"key":"1437_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6908a1","volume":"69","author":"LA Grohskopf","year":"2020","unstructured":"Grohskopf, L. A. et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices - United States, 2020-21 Influenza Season. MMWR Recomm. Rep. 69, 1\u201324 (2020).","journal-title":"MMWR Recomm. Rep."},{"key":"1437_CR5","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/s41577-024-01030-8","volume":"24","author":"TR Mosmann","year":"2024","unstructured":"Mosmann, T. R., McMichael, A. J., LeVert, A., McCauley, J. W. & Almond, J. W. Opportunities and challenges for T cell-based influenza vaccines. Nat. Rev. Immunol. 24, 736\u2013752 (2024).","journal-title":"Nat. Rev. Immunol."},{"key":"1437_CR6","doi-asserted-by":"publisher","unstructured":"Shi, W., Wohlwend, J., Wu, M. & Barzilay, R. Influenza vaccine strain selection with an AI-based evolutionary and antigenicity model. Nat. Med. https:\/\/doi.org\/10.1038\/s41591-025-03917-y (2025).","DOI":"10.1038\/s41591-025-03917-y"},{"key":"1437_CR7","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S1473-3099(16)00129-8","volume":"16","author":"EA Belongia","year":"2016","unstructured":"Belongia, E. A. et al. Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies. Lancet Infect. Dis. 16, 942\u2013951 (2016).","journal-title":"Lancet Infect. Dis."},{"key":"1437_CR8","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.jinf.2017.09.010","volume":"75","author":"M Rondy","year":"2017","unstructured":"Rondy, M. et al. Effectiveness of influenza vaccines in preventing severe influenza illness among adults: a systematic review and meta-analysis of test-negative design case-control studies. J. Infect. 75, 381\u2013394 (2017).","journal-title":"J. Infect."},{"key":"1437_CR9","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1080\/21645515.2018.1462639","volume":"14","author":"JD Allen","year":"2018","unstructured":"Allen, J. D. & Ross, T. M. H3N2 influenza viruses in humans: Viral mechanisms, evolution, and evaluation. Hum. Vaccin Immunother. 14, 1840\u20131847 (2018).","journal-title":"Hum. Vaccin Immunother."},{"key":"1437_CR10","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1172\/JCI57834","volume":"121","author":"S Sasaki","year":"2011","unstructured":"Sasaki, S. et al. Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies. J. Clin. Invest 121, 3109\u20133119 (2011).","journal-title":"J. Clin. Invest"},{"key":"1437_CR11","doi-asserted-by":"publisher","first-page":"e1002920","DOI":"10.1371\/journal.ppat.1002920","volume":"8","author":"S Khurana","year":"2012","unstructured":"Khurana, S., Frasca, D., Blomberg, B. & Golding, H. AID activity in B cells strongly correlates with polyclonal antibody affinity maturation in-vivo following pandemic 2009-H1N1 vaccination in humans. PLoS Pathog. 8, e1002920 (2012).","journal-title":"PLoS Pathog."},{"key":"1437_CR12","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.vaccine.2015.11.058","volume":"34","author":"A Mosterin Hopping","year":"2016","unstructured":"Mosterin Hopping, A. et al. The confounded effects of age and exposure history in response to influenza vaccination. Vaccine 34, 540\u2013546 (2016).","journal-title":"Vaccine"},{"key":"1437_CR13","doi-asserted-by":"publisher","first-page":"8077","DOI":"10.1016\/j.vaccine.2010.10.023","volume":"28","author":"D Frasca","year":"2010","unstructured":"Frasca, D. et al. Intrinsic defects in B cell response to seasonal influenza vaccination in elderly humans. Vaccine 28, 8077\u20138084 (2010).","journal-title":"Vaccine"},{"key":"1437_CR14","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.chom.2019.01.002","volume":"25","author":"C Henry","year":"2019","unstructured":"Henry, C. et al. Influenza virus vaccination elicits poorly adapted B cell responses in elderly individuals. Cell Host Microbe 25, 357\u2013366.e356 (2019).","journal-title":"Cell Host Microbe"},{"key":"1437_CR15","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.it.2016.09.002","volume":"37","author":"AN Akbar","year":"2016","unstructured":"Akbar, A. N., Henson, S. M. & Lanna, A. Senescence of T lymphocytes: implications for enhancing human immunity. Trends Immunol. 37, 866\u2013876 (2016).","journal-title":"Trends Immunol."},{"key":"1437_CR16","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41590-021-00927-z","volume":"22","author":"M Mittelbrunn","year":"2021","unstructured":"Mittelbrunn, M. & Kroemer, G. Hallmarks of T cell aging. Nat. Immunol. 22, 687\u2013698 (2021).","journal-title":"Nat. Immunol."},{"key":"1437_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/srep25051","volume":"6","author":"JS Lefebvre","year":"2016","unstructured":"Lefebvre, J. S., Masters, A. R., Hopkins, J. W. & Haynes, L. Age-related impairment of humoral response to influenza is associated with changes in antigen specific T follicular helper cell responses. Sci. Rep. 6, 25051 (2016).","journal-title":"Sci. Rep."},{"key":"1437_CR18","doi-asserted-by":"publisher","unstructured":"Hill, D. L. et al. Impaired HA-specific T follicular helper cell and antibody responses to influenza vaccination are linked to inflammation in humans. Elife 10, https:\/\/doi.org\/10.7554\/eLife.70554 (2021).","DOI":"10.7554\/eLife.70554"},{"key":"1437_CR19","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.coviro.2016.01.016","volume":"16","author":"EJ Grant","year":"2016","unstructured":"Grant, E. J., Quinones-Parra, S. M., Clemens, E. B. & Kedzierska, K. Human influenza viruses and CD8(+) T cell responses. Curr. Opin. Virol. 16, 132\u2013142 (2016).","journal-title":"Curr. Opin. Virol."},{"key":"1437_CR20","doi-asserted-by":"publisher","first-page":"6333","DOI":"10.4049\/jimmunol.176.10.6333","volume":"176","author":"JE McElhaney","year":"2006","unstructured":"McElhaney, J. E. et al. T cell responses are better correlates of vaccine protection in the elderly. J. Immunol. 176, 6333\u20136339 (2006).","journal-title":"J. Immunol."},{"key":"1437_CR21","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1016\/j.vaccine.2009.01.136","volume":"27","author":"JE McElhaney","year":"2009","unstructured":"McElhaney, J. E. et al. Granzyme B: correlates with protection and enhanced CTL response to influenza vaccination in older adults. Vaccine 27, 2418\u20132425 (2009).","journal-title":"Vaccine"},{"key":"1437_CR22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3389\/fimmu.2016.00041","volume":"7","author":"JE McElhaney","year":"2016","unstructured":"McElhaney, J. E., Kuchel, G. A., Zhou, X., Swain, S. L. & Haynes, L. T-cell immunity to influenza in older adults: a pathophysiological framework for development of more effective vaccines. Front. Immunol. 7, 41 (2016).","journal-title":"Front. Immunol."},{"key":"1437_CR23","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s10522-018-9754-8","volume":"19","author":"EC Lorenzo","year":"2018","unstructured":"Lorenzo, E. C., Bartley, J. M. & Haynes, L. The impact of aging on CD4(+) T cell responses to influenza infection. Biogerontology 19, 437\u2013446 (2018).","journal-title":"Biogerontology"},{"key":"1437_CR24","doi-asserted-by":"publisher","first-page":"5896","DOI":"10.1016\/j.vaccine.2020.07.005","volume":"38","author":"D Van Baarle","year":"2020","unstructured":"Van Baarle, D. et al. Preventing infectious diseases for healthy ageing: The VITAL public-private partnership project. Vaccine 38, 5896\u20135904 (2020).","journal-title":"Vaccine"},{"key":"1437_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50760-9","volume":"15","author":"M Van der Heiden","year":"2024","unstructured":"Van der Heiden, M. et al. Multiple vaccine comparison in the same adults reveals vaccine-specific and age-related humoral response patterns: an open phase IV trial. Nat. Commun. 15, 6603 (2024).","journal-title":"Nat. Commun."},{"key":"1437_CR26","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.4049\/jimmunol.1301721","volume":"192","author":"AM Wertheimer","year":"2014","unstructured":"Wertheimer, A. M. et al. Aging and cytomegalovirus infection differentially and jointly affect distinct circulating T cell subsets in humans. J. Immunol. 192, 2143\u20132155 (2014).","journal-title":"J. Immunol."},{"key":"1437_CR27","doi-asserted-by":"publisher","first-page":"e1010152","DOI":"10.1371\/journal.ppat.1010152","volume":"17","author":"SPH Van den Berg","year":"2021","unstructured":"Van den Berg, S. P. H. et al. Quantification of T-cell dynamics during latent cytomegalovirus infection in humans. PLoS Pathog. 17, e1010152 (2021).","journal-title":"PLoS Pathog."},{"key":"1437_CR28","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.4049\/jimmunol.2200369","volume":"209","author":"JA Breznik","year":"2022","unstructured":"Breznik, J. A. et al. Cytomegalovirus seropositivity in older adults changes the T cell repertoire but does not prevent antibody or cellular responses to SARS-CoV-2 vaccination. J. Immunol. 209, 1892\u20131905 (2022).","journal-title":"J. Immunol."},{"key":"1437_CR29","doi-asserted-by":"publisher","first-page":"3528","DOI":"10.4049\/jimmunol.1302503","volume":"193","author":"RS Herati","year":"2014","unstructured":"Herati, R. S. et al. Circulating CXCR5+PD-1+ response predicts influenza vaccine antibody responses in young adults but not elderly adults. J. Immunol. 193, 3528\u20133537 (2014).","journal-title":"J. Immunol."},{"key":"1437_CR30","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1093\/cid\/ciu680","volume":"59","author":"HQ McLean","year":"2014","unstructured":"McLean, H. Q. et al. Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons. Clin. Infect. Dis. 59, 1375\u20131385 (2014).","journal-title":"Clin. Infect. Dis."},{"key":"1437_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-024-01057-x","volume":"10","author":"SG Sullivan","year":"2025","unstructured":"Sullivan, S. G. et al. Antibody responses against influenza A decline with successive years of annual influenza vaccination. NPJ Vaccines 10, 11 (2025).","journal-title":"NPJ Vaccines"},{"key":"1437_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-025-01259-x","volume":"10","author":"MC Trieu","year":"2025","unstructured":"Trieu, M. C. et al. Effects of repeated influenza vaccination and infection on durable seroprotection in healthcare workers. NPJ Vaccines 10, 213 (2025).","journal-title":"NPJ Vaccines"},{"key":"1437_CR33","doi-asserted-by":"publisher","first-page":"14001","DOI":"10.1073\/pnas.96.24.14001","volume":"96","author":"DJ Smith","year":"1999","unstructured":"Smith, D. J., Forrest, S., Ackley, D. H. & Perelson, A. S. Variable efficacy of repeated annual influenza vaccination. Proc. Natl. Acad. Sci. USA 96, 14001\u201314006 (1999).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1437_CR34","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.cell.2014.03.031","volume":"157","author":"JS Tsang","year":"2014","unstructured":"Tsang, J. S. et al. Global analyses of human immune variation reveal baseline predictors of postvaccination responses. Cell 157, 499\u2013513 (2014).","journal-title":"Cell"},{"key":"1437_CR35","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1128\/JVI.02871-14","volume":"89","author":"SF Andrews","year":"2015","unstructured":"Andrews, S. F. et al. High preexisting serological antibody levels correlate with diversification of the influenza vaccine response. J. Virol. 89, 3308\u20133317 (2015).","journal-title":"J. Virol."},{"key":"1437_CR36","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/imr.12864","volume":"296","author":"D Frasca","year":"2020","unstructured":"Frasca, D., Blomberg, B. B., Garcia, D., Keilich, S. R. & Haynes, L. Age-related factors that affect B cell responses to vaccination in mice and humans. Immunol. Rev. 296, 142\u2013154 (2020).","journal-title":"Immunol. Rev."},{"key":"1437_CR37","doi-asserted-by":"publisher","first-page":"33581","DOI":"10.18632\/oncotarget.9254","volume":"7","author":"JS Lefebvre","year":"2016","unstructured":"Lefebvre, J. S. et al. Vaccine efficacy and T helper cell differentiation change with aging. Oncotarget 7, 33581\u201333594 (2016).","journal-title":"Oncotarget"},{"key":"1437_CR38","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1084\/jem.184.5.1891","volume":"184","author":"PJ Linton","year":"1996","unstructured":"Linton, P. J., Haynes, L., Klinman, N. R. & Swain, S. L. Antigen-independent changes in naive CD4 T cells with aging. J. Exp. Med 184, 1891\u20131900 (1996).","journal-title":"J. Exp. Med"},{"key":"1437_CR39","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/infdis\/jiz433","volume":"222","author":"KA Richards","year":"2020","unstructured":"Richards, K. A. et al. Evidence that blunted CD4 T-cell responses underlie deficient protective antibody responses to influenza vaccines in repeatedly vaccinated human subjects. J. Infect. Dis. 222, 273\u2013277 (2020).","journal-title":"J. Infect. Dis."},{"key":"1437_CR40","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/j.vaccine.2015.01.071","volume":"33","author":"D Frasca","year":"2015","unstructured":"Frasca, D., Diaz, A., Romero, M., Landin, A. M. & Blomberg, B. B. Cytomegalovirus (CMV) seropositivity decreases B cell responses to the influenza vaccine. Vaccine 33, 1433\u20131439 (2015).","journal-title":"Vaccine"},{"key":"1437_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.103852","volume":"76","author":"F Nicoli","year":"2022","unstructured":"Nicoli, F. et al. Primary immune responses are negatively impacted by persistent herpesvirus infections in older people: results from an observational study on healthy subjects and a vaccination trial on subjects aged more than 70 years old. EBioMedicine 76, 103852 (2022).","journal-title":"EBioMedicine"},{"key":"1437_CR42","doi-asserted-by":"publisher","unstructured":"Nicoli, F., Karrer, U. & Appay, V. Impact of CMV infection on heterologous vaccine responsiveness. Phil. Trans. R. Soc. B 380, https:\/\/doi.org\/10.1098\/rstb.2024.0407 (2025).","DOI":"10.1098\/rstb.2024.0407"},{"key":"1437_CR43","doi-asserted-by":"publisher","first-page":"3624","DOI":"10.4049\/jimmunol.1303361","volume":"193","author":"E Derhovanessian","year":"2014","unstructured":"Derhovanessian, E. et al. Latent infection with cytomegalovirus is associated with poor memory CD4 responses to influenza A core proteins in the elderly. J. Immunol. 193, 3624\u20133631 (2014).","journal-title":"J. Immunol."},{"key":"1437_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.663664","volume":"12","author":"SPH van den Berg","year":"2021","unstructured":"van den Berg, S. P. H. et al. Latent CMV infection is associated with lower influenza virus-specific memory T-cell frequencies, but not with an impaired T-cell response to acute influenza virus infection. Front. Immunol. 12, 663664 (2021).","journal-title":"Front. Immunol."},{"key":"1437_CR45","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41590-019-0320-6","volume":"20","author":"M Koutsakos","year":"2019","unstructured":"Koutsakos, M. et al. Human CD8(+) T cell cross-reactivity across influenza A, B and C viruses. Nat. Immunol. 20, 613\u2013625 (2019).","journal-title":"Nat. Immunol."},{"key":"1437_CR46","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1056\/NEJMoa1315727","volume":"371","author":"CA DiazGranados","year":"2014","unstructured":"DiazGranados, C. A. et al. Efficacy of high-dose versus standard-dose influenza vaccine in older adults. N. Engl. J. Med. 371, 635\u2013645 (2014).","journal-title":"N. Engl. J. Med."},{"key":"1437_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-425","volume":"14","author":"RB Couch","year":"2014","unstructured":"Couch, R. B. et al. Superior antigen-specific CD4+ T-cell response with AS03-adjuvantation of a trivalent influenza vaccine in a randomised trial of adults aged 65 and older. BMC Infect. Dis. 14, 425 (2014).","journal-title":"BMC Infect. Dis."},{"key":"1437_CR48","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.vaccine.2016.12.011","volume":"35","author":"A Domnich","year":"2017","unstructured":"Domnich, A. et al. Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: a systematic review and meta-analysis. Vaccine 35, 513\u2013520 (2017).","journal-title":"Vaccine"},{"key":"1437_CR49","doi-asserted-by":"publisher","unstructured":"Fox, A. et al. Enhanced influenza vaccines extend A(H3N2) antibody reactivity in older adults but prior vaccination effects persist. Clin. Infect. Dis. https:\/\/doi.org\/10.1093\/cid\/ciaf060 (2025).","DOI":"10.1093\/cid\/ciaf060"},{"key":"1437_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2025.126791","volume":"51","author":"BJ Essink","year":"2025","unstructured":"Essink, B. J. et al. A randomised phase 2 immunogenicity and safety study of a MF59-adjuvanted quadrivalent subunit inactivated cell-derived influenza vaccine (aQIVc) in adults aged 50 years and older. Vaccine 51, 126791 (2025).","journal-title":"Vaccine"},{"key":"1437_CR51","doi-asserted-by":"publisher","first-page":"e192","DOI":"10.1093\/cid\/ciaf060","volume":"81","author":"A Fox","year":"2025","unstructured":"Fox, A. et al. Enhanced influenza vaccines extend A(H3N2) antibody reactivity in older adults but prior vaccination effects persist. Clin. Infect. Dis. 81, e192\u2013e201 (2025).","journal-title":"Clin. Infect. Dis."},{"key":"1437_CR52","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1093\/infdis\/jix268","volume":"216","author":"J van Beek","year":"2017","unstructured":"van Beek, J. et al. Influenza-like illness incidence is not reduced by influenza vaccination in a cohort of older adults, despite effectively reducing laboratory-confirmed influenza virus infections. J. Infect. Dis. 216, 415\u2013424 (2017).","journal-title":"J. Infect. Dis."},{"key":"1437_CR53","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jcv.2014.11.033","volume":"63","author":"MJ Korndewal","year":"2015","unstructured":"Korndewal, M. J. et al. Cytomegalovirus infection in the Netherlands: seroprevalence, risk factors, and implications. J. Clin. Virol. 63, 53\u201358 (2015).","journal-title":"J. Clin. Virol."},{"key":"1437_CR54","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12979-020-00191-z","volume":"17","author":"LD Samson","year":"2020","unstructured":"Samson, L. D. et al. In-depth immune cellular profiling reveals sex-specific associations with frailty. Immun. Ageing 17, 20 (2020).","journal-title":"Immun. Ageing"},{"key":"1437_CR55","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/cyto.a.21015","volume":"79","author":"M Roederer","year":"2011","unstructured":"Roederer, M., Nozzi, J. L. & Nason, M. C. SPICE: exploration and analysis of post-cytometric complex multivariate datasets. Cytom. A 79, 167\u2013174 (2011).","journal-title":"Cytom. A"},{"key":"1437_CR56","doi-asserted-by":"publisher","first-page":"e42403","DOI":"10.1371\/journal.pone.0042403","volume":"7","author":"M Larsen","year":"2012","unstructured":"Larsen, M. et al. Evaluating cellular polyfunctionality with a novel polyfunctionality index. PLoS One 7, e42403 (2012).","journal-title":"PLoS One"}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01437-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01437-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01437-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:12:27Z","timestamp":1781568747000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01437-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1437"],"URL":"https:\/\/doi.org\/10.1038\/s41541-026-01437-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7818000\/v1","asserted-by":"object"}]},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"assertion":[{"value":"9 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"117"}}